GUAIFENESIN AND DEXTROMETHORPHAN HYDROBR

The Defense Logistics Agency awarded a delivery order to Cardinal Health, Inc. under the base contract SPE2DX-25-D-8022 for the supply of 16 units of Guaifenesin and Dextromethorphan Hydrobromide, identified by NSN 6505015603527, at a total value of $107.04. The award, issued on July 20, 2026, was made as a single line item under solicitation SPE2D926F7453, with performance directed to the USS CHARLESTON LCS 18 at FPO AP 96694 under FOB Destination terms, meaning the contractor is responsible for all transportation costs and risk until delivery. The order is issued against a commercial item acquisition framework using Standard Form 1449, and the award appears to follow a Lowest Price Technically Acceptable (LPTA) methodology given the minimal value, lack of technical evaluation criteria, and use of Fast Pay Net 15 payment terms. Cardinal Health, Inc., designated as a Small Business and Economically Disadvantaged Woman-Owned Small Business (EDDOSB), holds CAGE code 00E55 and is required to ensure packaging complies with traceable shipment methods, excluding parcel post, and to clearly mark all packages with the contract and delivery order numbers. Inspection and acceptance will occur at the destination by an authorized government representative, contingent upon the product conforming to the contract specifications without reference to external standards such as MIL-STD or USP. Payment will be processed via the Defense Finance and Accounting Service using account code BX: 97X4930 5CBX 001 2620 S33189, with invoices submitted by mail to Columbus, Ohio. No contract clauses, special requirements, or barcoding standards were explicitly included in the documentation, and there is no designated Contracting Officer's Representative or technical monitor named. The delivery is a one-time event with no options or extensions, and administrative oversight is managed by Lisa Quinn, the Contracting Officer, with support from Catherine Gilbert and Michelle Pampel.